Newmedical Technology, Inc.

Newmedical Technology, Inc. is a trailblazer in the Health Care and Pharmaceutical industries, specializing in innovative post-procedural care and recovery products for wound care, scars, bruising, and swelling. Since 2003, the company has been a global leader in aesthetic scar management, bruise recovery, and advanced wound care. Their flagship brands, NEWGEL™ and SILAGEN®, are highly acclaimed and widely recommended by physicians worldwide for scar therapy, offering medical-grade silicone gel and sheeting for scar prevention and management.

One of their standout products, BruiseMD®, has been recognized as one of the most effective options for post-procedure recovery, both surgical and non-surgical. Additionally, Devrasorb® presents innovative foam dressings designed to enhance wound cleansing and accelerate healing in diverse wound environments. These products are manufactured in a state-of-the-art facility ISO 13485 FDA registered facility in Northbrook, Illinois and are available in over 30 countries.

While the company's last investment details are currently unavailable, its groundbreaking solutions and global presence make it an appealing prospect for potential venture capital investors seeking to tap into the lucrative health and pharmaceutical market, with a focus on post-surgical care and wound management products.